BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12540499)

  • 1. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
    Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of vitamin D receptor FokI start codon polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal women in Taiwan.
    Chen HY; Chen WC; Hsu CD; Tsai FJ; Tsai CH
    Acta Obstet Gynecol Scand; 2002 Feb; 81(2):93-8. PubMed ID: 11942896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the vitamin D receptor start codon polymorphism (FokI) with bone mineral density in postmenopausal Korean women.
    Choi YM; Jun JK; Choe J; Hwang D; Park SH; Ku SY; Kang D; Kim JG; Moon SY; Lee JY
    J Hum Genet; 2000; 45(5):280-3. PubMed ID: 11043509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women.
    Gennari L; Becherini L; Mansani R; Masi L; Falchetti A; Morelli A; Colli E; Gonnelli S; Cepollaro C; Brandi ML
    J Bone Miner Res; 1999 Aug; 14(8):1379-86. PubMed ID: 10457270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women.
    Gross C; Eccleshall TR; Malloy PJ; Villa ML; Marcus R; Feldman D
    J Bone Miner Res; 1996 Dec; 11(12):1850-5. PubMed ID: 8970885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor start codon polymorphism ( FokI) is related to bone mineral density in healthy adolescent boys.
    Strandberg S; Nordström P; Lorentzon R; Lorentzon M
    J Bone Miner Metab; 2003; 21(2):109-13. PubMed ID: 12601576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones.
    Vezzoli G; Soldati L; Proverbio MC; Adamo D; Rubinacci A; Bianchi G; Mora S
    J Nephrol; 2002; 15(2):158-64. PubMed ID: 12018632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants.
    Gross C; Krishnan AV; Malloy PJ; Eccleshall TR; Zhao XY; Feldman D
    J Bone Miner Res; 1998 Nov; 13(11):1691-9. PubMed ID: 9797477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease.
    Bregenzer N; Schäffler A; Gelbmann CM; Steinkamp M; Reinshagen M; Schölmerich J; Andus T
    Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):1-5. PubMed ID: 16450309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
    Cicek MS; Liu X; Schumacher FR; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2549-52. PubMed ID: 17164384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.
    Huang SP; Huang CY; Wu WJ; Pu YS; Chen J; Chen YY; Yu CC; Wu TT; Wang JS; Lee YH; Huang JK; Huang CH; Wu MT
    Int J Cancer; 2006 Oct; 119(8):1902-7. PubMed ID: 16708371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
    Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
    J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor polymorphisms and lethal prostate cancer.
    Kibel AS; Isaacs SD; Isaacs WB; Bova GS
    J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese.
    Wong HL; Seow A; Arakawa K; Lee HP; Yu MC; Ingles SA
    Carcinogenesis; 2003 Jun; 24(6):1091-5. PubMed ID: 12807755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients.
    Nieto G; Barber Y; Rubio MC; Rubio M; Fibla J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):199-207. PubMed ID: 15225772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
    Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.